This is a synthetic peptide designed for use in combination with anti-LPL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Alias Symbols: HDLCQ11, LIPD
Protein Interaction Partner: APOC2,ASCC2,CALR,CETP,COPS6,KIAA1377,LPL,LRP1,LRP2,LUC7L2,PTPN4,RPL18A,UBE2Z,VLDLR,ASCC2,COPS6,EMD,KIAA1377,LRP1,LRP2,LUC7L2,PLK1,PTPN4,RPL18A,UBE2Z,VLDLR